UK NSC Recommendations
This list summarises whether population screening is currently recommended for a condition or not, and if it is open to public comments at this time.
Recommendations are reviewed regularly, usually every 3 years. Use the filters to read the details of the findings and supporting documents from the most recent review.
Showing 21 – 32 of 32 results
| Condition | Who it affects | Screening recommended | Public comments |
|---|---|---|---|
| Kernicterus | Newborn | Not recommended | |
| LCHADD | Newborn | Not recommended | |
| MCADD | Newborn | Recommended | |
| Metachromatic leukodystrophy | Newborn | Not recommended | |
| MPS I | Newborn | Not recommended | |
| MSUD | Newborn | Recommended | |
| Organic acid oxidation disorders | Newborn | Not recommended | |
| PKU | Newborn | Recommended | |
| SCID | Newborn | Not recommended | |
| Sickle cell disease (newborn) | Newborn | Recommended | |
| Spinal muscular atrophy | Antenatal, Newborn | Not recommended | |
| Tyrosinaemia type 1 | Newborn | Recommended |